Corrado Tarella

10.3k total citations · 1 hit paper
213 papers, 6.2k citations indexed

About

Corrado Tarella is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Corrado Tarella has authored 213 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pathology and Forensic Medicine, 86 papers in Oncology and 71 papers in Hematology. Recurrent topics in Corrado Tarella's work include Lymphoma Diagnosis and Treatment (110 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Hematopoietic Stem Cell Transplantation (37 papers). Corrado Tarella is often cited by papers focused on Lymphoma Diagnosis and Treatment (110 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Hematopoietic Stem Cell Transplantation (37 papers). Corrado Tarella collaborates with scholars based in Italy, United States and Egypt. Corrado Tarella's co-authors include Alessandro Pileri, Marco Bregni, Paolo Corradini, Salvatore Siena, Gianni Bonadonna, Alessandro M. Gianni, Marco Ladetto, Mario Boccadoro, Daniele Caracciolo and Dario Ferrero and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Corrado Tarella

201 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

1989 588 citations Marco Bregni, Salvatore Siena et al. The Lancet profile →

Peers

Countries citing papers authored by Corrado Tarella

Since Specialization

Citations

This map shows the geographic impact of Corrado Tarella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corrado Tarella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corrado Tarella more than expected).

Fields of papers citing papers by Corrado Tarella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corrado Tarella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corrado Tarella. The network helps show where Corrado Tarella may publish in the future.

Co-authorship network of co-authors of Corrado Tarella

This figure shows the co-authorship network connecting the top 25 collaborators of Corrado Tarella. A scholar is included among the top collaborators of Corrado Tarella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corrado Tarella. Corrado Tarella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune Signatures Identify Patient Subsets Deriving Long‐Term Benefit From First‐Line Rituximab in Follicular Lymphoma 2025 ·eJHaem ·(unknown), (unknown), Valentina Tabanelli, Maria Rosaria Sapienza, Federica Melle, Giovanna Motta, Marcello Del Corvo, Angelica Calleri, Anna Vanazzi, (unknown), (unknown), (unknown), (unknown), Roberto Chiarle, (unknown), Corrado Tarella, Enrico Derenzini	1
2	Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials 2025 ·Blood Cancer Journal ·Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stéphane Chauvie, Michael V. Knopp, Stefano Luminari, Daniel Molin, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella	0
3	Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes 2025 ·Frontiers in Immunology ·Alberto Mella, (unknown), Valeria Deiana, (unknown), (unknown), Ester Gallo, (unknown), (unknown), (unknown), Fabrizio Fop, (unknown), Federica Cavallo, (unknown), Dario Ferrero, Roberto Mina, Corrado Tarella, Benedetto Bruno, Filippo Mariano, (unknown)	1
4	[ ¹⁸ F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphoma 2023 ·Hematological Oncology ·Laura Lavinia Travaini, Francesca Botta, Enrico Derenzini, (unknown), Mahila Ferrari, (unknown), Tommaso Radice, Saveria Mazzara, Corrado Tarella, Stefano Pileri, Sara Raimondi, Francesco Ceci	4
5	G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 2020 ·BMJ Open ·Paolina Salamone, Giuseppe Fuda, Federico Casale, Giuseppe Marrali, Christian Lunetta, Claudia Caponnetto, Letizia Mazzini, Vincenzo La Bella, Jessica Mandrioli, Isabella Laura Simone, Cristina Moglia, Andrea Calvo, Corrado Tarella, Adriano Chiò	10
6	Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation Guidelines for the Management of Indolent, Nonfollicular B-Cell Lymphoma (Marginal Zone, Lymphoplasmacytic, and Small Lymphocytic Lymphoma) 2014 ·Clinical Lymphoma Myeloma & Leukemia ·Corrado Tarella, Luca Arcaini, Luca Baldini, Giovanni Barosi, Atto Billio, Monia Marchetti, Alessandro Rambaldi, Umberto Vitolo, Pier Luigi Zinzani, S Tura	19
7	Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival 2014 ·PLoS ONE ·Corrado Tarella, Angela Gueli, Federica Delaini, Andrea Rossi, Anna Maria Barbui, Giuseppe Gritti, Cristina Boschini, Daniele Caracciolo, Riccardo Bruna, Marco Ruella, Daniela Gottardi, Roberto Passera, Alessandro Rambaldi	17
8	Phase II study of sorafenib in patients with relapsed or refractory lymphoma 2012 ·British Journal of Haematology ·Anna Guidetti, Carmelo Carlo‐Stella, Silvia L. Locatelli, Walter Malorni, Marina Pierdominici, Cristiana Barbati, Roberta Mortarini, Liliana Devizzi, Paola Matteucci, Alfonso Marchianò, Rodolfo Lanocita, Lucia Farina, Anna Dodero, Corrado Tarella, Massimo Di Nicola, Paolo Corradini, Andrea Anichini, Alessandro M. Gianni	38
9	The aging effect of chemotherapy on cultured human mesenchymal stem cells 2011 ·Experimental Hematology ·Stefano Buttiglieri, Marco Ruella, Alessandra Risso, Tiziana Spatola, Lorenzo Silengo, Enrico V. Avvedimento, Corrado Tarella	57
10	Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte–colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial 2010 ·Cytotherapy ·Corrado Tarella, Sergio Rutella, Francesca Gualandi, Mario Melazzini, Rosanna Scimè, Mario Petrini, Cristina Moglia, Marco Ulla, Paola Omedè, Vincenzo La Bella, Massimo Corbo, Vincenzo Silani, Gabriele Siciliano, Gabriele Mora, Claudia Caponnetto, Mario Sabatelli, Adriano Chiò	32
11	Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease 2006 ·Journal of Hepatology ·Silvia Gaia, Antonina Smedile, Paola Omedè, Antonella Olivero, F Sanavio, F. Balzola, A. Ottobrelli, Maria Lorena Abate, Alfredo Marzano, Mario Rizzetto, Corrado Tarella	136
12	Bone marrow transplantation for lymphoma CR1 2005 ·Current Opinion in Oncology ·Corrado Tarella, Alessandro M. Gianni	7
13	Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone 2003 ·Experimental Hematology ·Marco Ladetto, Barbara Mantoan, Irene Ricca, Monica Astolfi, Daniela Drandi, Mara Compagno, Sonia Vallet, Maria Elena Dell’Aquila, A Alfarano, (unknown), Alberto Rocci, Umberto Vitolo, Paolo Corradini, Mario Boccadoro, Corrado Tarella	9
14	Intensification of salvage treatment with high‐dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non‐Hodgkin's lymphoma 2001 ·British Journal of Haematology ·Sergio Cortelazzo, Alessandro Rambaldi, Andrea Rossi, Elena Oldani, Michele Ghielmini, Fabio Benedetti, Corrado Tarella, (unknown), Umberto Vitolo, Massimo Di Nicola, Enrico Pogliani, F. Cavalli, Alessandro M. Gianni, Tiziano Barbui	29
15	Allografting for patients with advanced hematological malignancies: non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with hsv thymidine kinase gene 2000 ·Blood ·Paolo Corradini, Corrado Tarella, Marco Bregni, Paola Carrera, Magda Marcatti, Alessandra Pescarollo, Fabio Ciceri, Andrés J.M. Ferreri, Alessandro M. Gianni, Claudio Bordignon	1
16	Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategies 1999 ·Leukemia ·Paolo Corradini, Marco Ladetto, Alessandro Pileri, Corrado Tarella	37
17	G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs 1998 ·Bone Marrow Transplantation ·Corrado Tarella, Claudia Castellino, Francesco Locatelli, (unknown), Paolo Corradini, M Falda, Anna Novarino, (unknown), Alessandro Pileri	52
18	Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration. 1993 ·PubMed ·M. Bazzan, (unknown), Corrado Tarella, Stefania Stella, (unknown), Alessandro Pileri, G. Tamponi	3
19	Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoietic stem cells for autransplantation. 1989 ·The Lancet ·Gianni Am, Salvatore Siena, Marco Bregni, Corrado Tarella, Stern Ac, Alessandro Pileri, G. Bonadonna	31
20	Ras oncogene mutation in multiple myeloma. 1989 ·The Journal of Experimental Medicine ·Antonino Neri, James P. Murphy, Lilla Cro, Dario Ferrero, Corrado Tarella, Luca Baldini, Riccardo Dalla‐Favera	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact